A

Abbott India Ltd
NSE:ABBOTINDIA

Watchlist Manager
Abbott India Ltd
NSE:ABBOTINDIA
Watchlist
Price: 27 718.5 INR 2.23% Market Closed
Market Cap: 589B INR
Have any thoughts about
Abbott India Ltd?
Write Note

Relative Value

The Relative Value of one ABBOTINDIA stock under the Base Case scenario is 25 326.36 INR. Compared to the current market price of 27 718.5 INR, Abbott India Ltd is Overvalued by 9%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

ABBOTINDIA Relative Value
Base Case
25 326.36 INR
Overvaluation 9%
Relative Value
Price
A
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
20
vs Industry
14
Median 3Y
9
Median 5Y
8.4
Industry
2.5
Forward
8.9
vs History
60
vs Industry
9
Median 3Y
49.5
Median 5Y
49.2
Industry
21.9
Forward
43.3
vs History
42
vs Industry
8
Median 3Y
47.5
Median 5Y
48.4
Industry
16.5
vs History
46
vs Industry
11
Median 3Y
52.6
Median 5Y
53
Industry
23.6
vs History
17
vs Industry
4
Median 3Y
15.6
Median 5Y
15
Industry
2.1
vs History
20
vs Industry
14
Median 3Y
9
Median 5Y
7.9
Industry
2.6
Forward
8.6
vs History
22
vs Industry
8
Median 3Y
20
Median 5Y
17.6
Industry
5.2
vs History
31
vs Industry
8
Median 3Y
38.3
Median 5Y
37.4
Industry
13.3
Forward
34
vs History
34
vs Industry
9
Median 3Y
40.6
Median 5Y
39.3
Industry
16.6
Forward
35.7
vs History
39
vs Industry
9
Median 3Y
45.9
Median 5Y
46.1
Industry
15.6
vs History
36
vs Industry
9
Median 3Y
47.8
Median 5Y
47.8
Industry
19.1
vs History
82
vs Industry
4
Median 3Y
29.4
Median 5Y
38
Industry
1.9

Multiples Across Competitors

ABBOTINDIA Competitors Multiples
Abbott India Ltd Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
IN
Abbott India Ltd
NSE:ABBOTINDIA
589B INR 9.9 47.5 38.3 40.2
JP
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
776 550.9T JPY 4 211 733 -5 347 888.9 -5 459 134.4 -5 046 864.6
US
Eli Lilly and Co
NYSE:LLY
710.5B USD 17.4 84.9 45.7 51
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP 578.3 -15 783.5 3 846.3 17 702.3
DK
Novo Nordisk A/S
CSE:NOVO B
3.3T DKK 12.3 35 24.3 27.8
US
Johnson & Johnson
NYSE:JNJ
373.5B USD 4.3 25.4 12.3 16
US
Merck & Co Inc
NYSE:MRK
251.1B USD 4 20.7 10.5 12.5
CH
Roche Holding AG
SIX:ROG
202.7B CHF 3.5 17.6 9.9 11.8
CH
Novartis AG
SIX:NOVN
183.3B CHF 4.1 11.6 10.1 14
UK
AstraZeneca PLC
LSE:AZN
162.4B GBP 4.1 31.6 169.4 253.9
IE
Endo International PLC
LSE:0Y5F
146B USD 63 -49.9 234.4 587.7
P/E Multiple
Earnings Growth
IN
A
Abbott India Ltd
NSE:ABBOTINDIA
Average P/E: 34.3
47.5
37%
JP
N
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
Negative Multiple: -5 347 888.9 N/A
US
Eli Lilly and Co
NYSE:LLY
84.9
451%
UK
Dechra Pharmaceuticals PLC
LSE:DPH
Negative Multiple: -15 783.5 N/A
DK
Novo Nordisk A/S
CSE:NOVO B
35
86%
US
Johnson & Johnson
NYSE:JNJ
25.4
-22%
US
Merck & Co Inc
NYSE:MRK
20.7
7 321%
CH
Roche Holding AG
SIX:ROG
17.6
32%
CH
Novartis AG
SIX:NOVN
11.6
21%
UK
AstraZeneca PLC
LSE:AZN
31.6
177%
IE
E
Endo International PLC
LSE:0Y5F
Negative Multiple: -49.9 N/A

See Also

Discover More
Back to Top